News & Events

• October 19, 2020 - October 19, 2020
  

  Workshop: RDCA-DAP 2020 Virtual Workshop

  Join us for the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) annual workshop and learn more about:

  – RDCA-DAP’s first year progress and development
  – How RDCA-DAP will work to accelerate rare disease drug development
  – How the platform works: improved ability to search and sort data
  – Case studies on how sharing patient-level data accelerates understanding of rare diseases
  – Ways to get involved and the benefits of engaging with RDCA-DAP

  Monday, October 19, 11 a.m. – 3:30 p.m. ET. Register now.

• June 24, 2020
  

  Webinar: Shortening the Timeline for Developing New Treatments – How the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) Can Help

  Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), an integrated database and analytics hub designed to be used in building novel tools to accelerate drug development across rare diseases.

  Wednesday, June 24 at 1 PM EDT. Register now.

• June 9, 2020
  

  Webinar: FDA Drug Topics: CURE ID: Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies in the Era of COVID-19

  This new webinar from the Center for Drug Evaluation (CDER), Division of Drug Information (DDI) is now available at:
  https://collaboration.fda.gov/p2aaislio098/

  The webinar is a demonstration of the CURE ID mobile app and web platform, developed by the U.S. Food and Drug Administration (FDA), in collaboration with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH). CURE ID gives the global clinical community the opportunity to report novel uses of existing drugs for patients with difficult to treat infectious diseases, including COVID-19. C-Path’s CURE Drug Repurposing Collaboratory (CDRC) is working directly with the FDA and NCATS/NIH on this initiative.

• May 6, 2020
  

  What You Need to Know About the Rare Disease Cures Accelerator-Data and Analytics Platform

  Join C-Path, the National Organization for Rare Disorders and the FDA for a free 1-hour webinar on the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP), an integrated database and analytics hub designed to be used in building novel tools to accelerate drug development across rare diseases. Wednesday, May 6 at 1 PM EDT. Register......
• March 30, 2020 - March 31, 2020
  

  POSTPONED: 2020 DIA Digital Technology in Clinical Trials Conference

  The ePRO Consortium is pleased to be a co-sponsor of the upcoming 2020 DIA Digital Technology in Clinical Trials Conference to be held from March 30-31, 2020 in Boston, MA. This multi-track conference will bring together thought-leaders from regulatory agencies, biotech, pharmaceutical, patients, and academia to discuss the latest advances, challenges, and forward-thinking approaches for......